Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-03-14, Stock:NVS, The news for the past five days is as follows:
2018-03-07: NEWS1: Pharmaceutical Industry Outlook - March 2018.NEWS2: Pharmaceutical Industry Outlook - March 2018.NEWS3: Pharmaceutical Industry Outlook - March 2018.NEWS4: Analyzing Gilead Sciences’ Other Products in 4Q17.NEWS5: Johnson & Johnson’s Consumer Segment in 4Q17.NEWS6: How Bristol-Myers Squibb’s Sprycel and Empliciti Performed in 4Q17.NEWS7: The Swiss Stock Market Finished Higher After Late Recovery.NEWS8: The Swiss Stock Market Finished Higher After Late Recovery.NEWS9: Novartis, U.S. partner plan remote trials to boost participation.NEWS10: Novartis, Science 37 Commit To Launch Up To 10 Trials Over Three Years.NEWS11: Novartis, Science 37 Commit To Launch Up To 10 Trials Over Three Years.
2018-03-08: NEWS1: Conatus (CNAT) Loss Narrower Than Expected in Q4, Sales Miss.NEWS2: Conatus (CNAT) Loss Narrower Than Expected in Q4, Sales Miss.NEWS3: Conatus (CNAT) Loss Narrower Than Expected in Q4, Sales Miss.NEWS4: Merck to Pay $300M Upfront to Co-Develop Eisai's Cancer Drug.NEWS5: Merck to Pay $300M Upfront to Co-Develop Eisai's Cancer Drug.NEWS6: The Swiss Stock Market Climbed As Trade Concerns Ease.NEWS7: The Swiss Stock Market Climbed As Trade Concerns Ease.NEWS8: [$$] Syriza is undermining democracy in Greece.
2018-03-09: NEWS1: How AstraZeneca’s Revenues Trended in 4Q17.NEWS2: The Swiss Stock Market Finished Higher After U.S. Jobs Report.NEWS3: The Swiss Stock Market Finished Higher After U.S. Jobs Report.
2018-03-12: NEWS1: How AstraZeneca’s Respiratory Products Performed in 4Q17.NEWS2: The Swiss Stock Market Is Approaching The 9,000 Point Level.NEWS3: The Swiss Stock Market Is Approaching The 9,000 Point Level.NEWS4: How AstraZeneca’s Business Segments Performed in 4Q17.NEWS5: Novartis CEO Narasimhan remakes drugmaker's leadership as Wyss exits.NEWS6: Novartis says operations head Wyss resigning, names three to executive panel.
2018-03-13: NEWS1: How Novartis’s Revenues Trended in 4Q17.NEWS2: What’s Novartis’s Valuation in March 2018?.NEWS3: How AstraZeneca’s Other Products Portfolio Performed in 4Q17.NEWS4: The Swiss Stock Market Dropped Following Afternoon Sell-Off.NEWS5: The Swiss Stock Market Dropped Following Afternoon Sell-Off.

Answer: Decrease